Detalhe da pesquisa
1.
Graves-PCD: protocol for a randomised, dose-finding, adaptive trial of the plasma cell-depleting agent daratumumab in severe Graves' disease.
BMJ Open
; 14(6): e079158, 2024 Jun 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-38866568
2.
Associations between AI-Assisted Tumor Amphiregulin and Epiregulin IHC and Outcomes from Anti-EGFR Therapy in the Routine Management of Metastatic Colorectal Cancer.
Clin Cancer Res
; 29(20): 4153-4165, 2023 10 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-37363997